Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma
暂无分享,去创建一个
Hiroyuki Honda | Toshiaki Saida | Kazuhiko Matsumoto | H. Honda | Takeshi Kobayashi | T. Saida | A. Ito | Kazuhiko Matsumoto | M. Shinkai | Kouji Tanaka | Takeshi Kobayashi | Akira Ito | Masashige Shinkai | Kouji Tanaka | Kazuyoshi Kondo | K. Kondo
[1] H. Honda,et al. Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes , 2003, Melanoma research.
[2] H. Honda,et al. Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles , 2003, Cancer Immunology, Immunotherapy.
[3] H. Honda,et al. Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia , 2001, Cancer Immunology, Immunotherapy.
[4] S. Kasaoka,et al. Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in rats. , 2000, International journal of oncology.
[5] A. Melcher,et al. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. , 1999, Journal of immunology.
[6] Jun Yoshida,et al. Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study. , 1999, Japanese journal of cancer research : Gann.
[7] J. Mulé,et al. Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[8] A. Menoret,et al. Heat-shock protein-based anticancer immunotherapy: an idea whose time has come. , 1998, Seminars in oncology.
[9] H. Honda,et al. Antitumor Immunity Induction by Intracellular Hyperthermia Using Magnetite Cationic Liposomes , 1998, Japanese journal of cancer research : Gann.
[10] P. Srivastava,et al. Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. , 1998, Immunity.
[11] H. Band,et al. Hsp72-mediated augmentation of MHC class I surface expression and endogenous antigen presentation. , 1998, International immunology.
[12] D. Hanahan,et al. Self Antigens Expressed by Solid Tumors Do Not Efficiently Stimulate Naive or Activated T Cells: Implications for Immunotherapy , 1997, The Journal of experimental medicine.
[13] Jun Yoshida,et al. Intracellular Hyperthermia for Cancer Using Magnetite Cationic Liposomes: Ex vivo Study , 1996, Japanese journal of cancer research : Gann.
[14] P. Matzinger,et al. Is cancer dangerous to the immune system? , 1996, Seminars in immunology.
[15] P. Srivastava,et al. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. , 1995, Science.
[16] Takeshi Kobayashi,et al. Heat Properties of Magnetoliposomes for Local Hyperthermia , 1994 .
[17] E. Jaffee,et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. Socinski,et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. , 1988, The New England journal of medicine.
[19] R. Bast,et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. , 1988, The New England journal of medicine.
[20] J. Gutterman,et al. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. , 1987, The New England journal of medicine.
[21] J. Groopman,et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. , 1987, The New England journal of medicine.
[22] J. Horiguchi,et al. Expression of the macrophage-specific colony-stimulating factor in human monocytes treated with granulocyte-macrophage colony-stimulating factor. , 1987, Blood.
[23] Y Onoyama,et al. Multi‐institutional studies on hyperthermia using an 8‐MHz radiofrequency capacitive heating device (thermotron RF‐8) in combination with radiation for cancer therapy , 1986, Cancer.
[24] D. Golde,et al. Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. , 1984, Science.
[25] J. Subjeck,et al. Heat shock proteins and protection of proliferation and translation in mammalian cells. , 1984, Cancer research.
[26] C. Owen,et al. Magnetic labeling and cell sorting. , 1984, Journal of immunological methods.
[27] M. Doyle,et al. Biological activity of recombinant human interleukin-2 produced in Escherichia coli. , 1984, Science.
[28] T. Flotte,et al. Dendritic cell and macrophage staining by monoclonal antibodies in tissue sections and epidermal sheets. , 1983, The American journal of pathology.
[29] M. McMahon,et al. Hyperthermia and the heat-shock proteins of HeLa cells. , 1982, British Journal of Cancer.
[30] W. Farrar,et al. Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. , 1981, Journal of immunology.
[31] A. Burgess,et al. The nature and action of granulocyte-macrophage colony stimulating factors. , 1980, Blood.
[32] J. Zee. Heating the patient : a promising approach ? , 2002 .
[33] R. Kiessling,et al. Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells. , 2001, Cancer research.
[34] Edgar G. Engleman,et al. Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells , 1996, Nature Medicine.
[35] H. Honda,et al. Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study. , 1996, Japanese journal of cancer research : Gann.
[36] P. Matzinger. Tolerance, danger, and the extended family. , 1994, Annual review of immunology.
[37] P. Wust,et al. Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. , 1993, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[38] R. Steinman,et al. The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.
[39] J. Hadden. Recent advances in the preclinical and clinical immunopharmacology of interleukin-2: emphasis on IL-2 as an immunorestorative agent. , 1988, Cancer detection and prevention.
[40] Hadden Jw. Recent advances in the preclinical and clinical immunopharmacology of interleukin-2: emphasis on IL-2 as an immunorestorative agent. , 1988 .